These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30587845)

  • 1. Prognostic Value of Hemoglobin A1c Levels in Postmenopausal Diabetic Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome.
    Lao Y; Feng L; Yuan Y; Zhang J; Huang X; Li M; Wu Z
    Med Sci Monit; 2018 Dec; 24():9399-9405. PubMed ID: 30587845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: A Cohort study.
    Zhang W; Kong Y; Wang L; Song L; Tan L; Xue X
    Medicine (Baltimore); 2020 Aug; 99(33):e20805. PubMed ID: 32871971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome.
    Wang C; Kong Y; Ding Y; Sun J; Chen T
    Med Sci Monit; 2019 Dec; 25():9517-9523. PubMed ID: 31834876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention (HbA1c < 6.5% at 2 years) in type 2 diabetes mellitus combined with acute coronary syndrome: a 5-years follow-up study.
    Yang T; Fu P; Chen J; Fu X; Xu C; Liu X; Niu T
    Curr Med Res Opin; 2021 Sep; 37(9):1517-1528. PubMed ID: 34166166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylated hemoglobin and outcomes in diabetic patients with acute myocardial infarction after successful revascularization with stent placement: findings from the guthrie health off-label stent (GHOST) investigators.
    Singla A; Orshaw P; Boura J; Harjai KJ
    J Interv Cardiol; 2012 Jun; 25(3):262-9. PubMed ID: 22376172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome.
    Wang C; Liao P; Tang C; Chen C; Zhang X
    Front Endocrinol (Lausanne); 2024; 15():1423227. PubMed ID: 39257901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome.
    Naito R; Miyauchi K; Ogita M; Kasai T; Kawaguchi Y; Tsuboi S; Konishi H; Okazaki S; Kurata T; Daida H
    J Cardiol; 2014 Feb; 63(2):106-11. PubMed ID: 24011926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation.
    Lemesle G; Bonello L; de Labriolle A; Maluenda G; Syed AI; Collins SD; Ben-Dor I; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Jul; 104(1):41-5. PubMed ID: 19576319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum resistin level and cardiovascular events in postmenopausal women with acute coronary syndrome undergoing percutaneous coronary intervention.
    Li L; Han JL; Mao JM; Guo LJ; Gao W
    Chin Med J (Engl); 2013 Mar; 126(6):1058-62. PubMed ID: 23506578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention.
    Zheng J; Cheng J; Zhang Q; Qi C; Wang T; Xiao X
    Medicine (Baltimore); 2016 May; 95(19):e3696. PubMed ID: 27175711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: an observational multicenter study.
    Tian L; Zhu J; Liu L; Liang Y; Li J; Yang Y
    Coron Artery Dis; 2013 Jan; 24(1):16-22. PubMed ID: 23168569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of glycosylated hemoglobin A1c and apolipoprotein A-1 ratio on predicting outcome of patients with acute coronary syndrome].
    Wang YJ; Mu HN; Yang RY; Zhang WD; Wang XY; Wang SM; Ji FS; Dong J; Yu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jan; 51(1):38-44. PubMed ID: 36655240
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
    Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the plasma glycosylated hemoglobin A1c/Apolipoprotein A-l ratio in predicting cardiovascular outcomes in acute coronary syndrome.
    Song F; Zhou Y; Zhang K; Liang YF; He X; Li L
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):570-578. PubMed ID: 33358616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of glucose metabolism for non-ST-segment elevation infarction patients with diabetes mellitus and single concomitant chronic total occlusion following primary percutaneous coronary intervention.
    Xing Z; Zhang L; Liu Z; He P; Yang Y; Wulasihan M
    Medicine (Baltimore); 2017 Nov; 96(45):e8362. PubMed ID: 29137017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
    Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
    Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.